Pro-Dex Stock Forecast, Price & News

+0.10 (+0.35 %)
(As of 06/21/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume9,976 shs
Average Volume26,308 shs
Market Capitalization$106.08 million
P/E Ratio29.58
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive PDEX News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter.

Pro-Dex logo

About Pro-Dex

Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and maxocranial facial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.73 out of 5 stars

Medical Sector

1293rd out of 2,105 stocks

Surgical & Medical Instruments Industry

117th out of 174 stocks

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Pro-Dex (NASDAQ:PDEX) Frequently Asked Questions

What stocks does MarketBeat like better than Pro-Dex?

Wall Street analysts have given Pro-Dex a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Pro-Dex wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Pro-Dex's next earnings date?

Pro-Dex is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for Pro-Dex

How were Pro-Dex's earnings last quarter?

Pro-Dex, Inc. (NASDAQ:PDEX) announced its earnings results on Friday, May, 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.28. The medical instruments supplier earned $11.74 million during the quarter. Pro-Dex had a trailing twelve-month return on equity of 30.20% and a net margin of 15.47%.
View Pro-Dex's earnings history

How has Pro-Dex's stock been impacted by Coronavirus (COVID-19)?

Pro-Dex's stock was trading at $18.24 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, PDEX stock has increased by 59.4% and is now trading at $29.08.
View which stocks have been most impacted by COVID-19

Who are Pro-Dex's key executives?

Pro-Dex's management team includes the following people:
  • Mr. Richard Lee Van Kirk Jr., CEO, Pres, COO & Director (Age 60, Pay $621.64k)
  • Ms. Alisha K. Charlton, CFO & Corp. Sec. (Age 51, Pay $248.95k)

What is Michael J. Berthelot's approval rating as Pro-Dex's CEO?

3 employees have rated Pro-Dex CEO Michael J. Berthelot on Michael J. Berthelot has an approval rating of 85% among Pro-Dex's employees.

Who are some of Pro-Dex's key competitors?

What other stocks do shareholders of Pro-Dex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pro-Dex investors own include KEMET (KEM), NVIDIA (NVDA), Enterprise Products Partners (EPD), Micron Technology (MU), AT&T (T), AbbVie (ABBV), Alibaba Group (BABA), Bank of America (BAC), Marvell Technology (MRVL) and UnitedHealth Group (UNH).

What is Pro-Dex's stock symbol?

Pro-Dex trades on the NASDAQ under the ticker symbol "PDEX."

Who are Pro-Dex's major shareholders?

Pro-Dex's stock is owned by a variety of institutional and retail investors. Top institutional investors include Acadian Asset Management LLC (2.30%), BlackRock Inc. (1.57%), Dimensional Fund Advisors LP (1.60%), Victory Capital Management Inc. (1.33%), LSV Asset Management (0.85%) and Geode Capital Management LLC (0.79%). Company insiders that own Pro-Dex stock include Alisha Charlton, Kirk Richard Lee Van Jr, Nicholas John Swenson, Raymond E Cabillot and William James Farrell III.
View institutional ownership trends for Pro-Dex

Which major investors are selling Pro-Dex stock?

PDEX stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Northern Trust Corp, Acadian Asset Management LLC, O Shaughnessy Asset Management LLC, and LSV Asset Management. Company insiders that have sold Pro-Dex company stock in the last year include Alisha Charlton, Kirk Richard Lee Van Jr, Nicholas John Swenson, Raymond E Cabillot, and William James Farrell III.
View insider buying and selling activity for Pro-Dex
or view top insider-selling stocks.

Which major investors are buying Pro-Dex stock?

PDEX stock was purchased by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Exchange Traded Concepts LLC, Fiera Capital Corp, Punch & Associates Investment Management Inc., Hussman Strategic Advisors Inc., Dimensional Fund Advisors LP, Geode Capital Management LLC, and BlackRock Inc..
View insider buying and selling activity for Pro-Dex
or or view top insider-buying stocks.

How do I buy shares of Pro-Dex?

Shares of PDEX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pro-Dex's stock price today?

One share of PDEX stock can currently be purchased for approximately $29.08.

How much money does Pro-Dex make?

Pro-Dex has a market capitalization of $106.08 million and generates $34.83 million in revenue each year.

How many employees does Pro-Dex have?

Pro-Dex employs 117 workers across the globe.

What is Pro-Dex's official website?

The official website for Pro-Dex is

Where are Pro-Dex's headquarters?

Pro-Dex is headquartered at 2361 MCGAW AVENUE, IRVINE CA, 92614.

How can I contact Pro-Dex?

Pro-Dex's mailing address is 2361 MCGAW AVENUE, IRVINE CA, 92614. The medical instruments supplier can be reached via phone at 949-769-3200 or via email at [email protected]

This page was last updated on 6/22/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.